254 related articles for article (PubMed ID: 27832203)
1. Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis.
Chen FA; Chien CC; Chen YW; Wu YT; Lin CC
PLoS One; 2016; 11(11):e0166362. PubMed ID: 27832203
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.
Jackson RS; Sidawy AN; Amdur RL; Khetarpal A; Macsata RA
J Vasc Surg; 2011 Dec; 54(6):1706-12. PubMed ID: 21840155
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients.
Doi S; Masaki T; Shigemoto K; Harada S; Yorioka N
Ther Apher Dial; 2008 Jun; 12(3):232-6. PubMed ID: 18503701
[TBL] [Abstract][Full Text] [Related]
4. Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.
Wang K; Zelnick LR; Imrey PB; deBoer IH; Himmelfarb J; Allon MD; Cheung AK; Dember LM; Roy-Chaudhury P; Vazquez MA; Kusek JW; Feldman HI; Beck GJ; Kestenbaum B;
Am J Nephrol; 2018; 48(1):56-64. PubMed ID: 30071516
[TBL] [Abstract][Full Text] [Related]
5. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
Sajgure A; Choudhury A; Ahmed Z; Choudhury D
Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
[TBL] [Abstract][Full Text] [Related]
7. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake?
Heine GH; Ulrich C; Köhler H; Girndt M
Am J Nephrol; 2004; 24(4):461-8. PubMed ID: 15331890
[TBL] [Abstract][Full Text] [Related]
8. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Use of Arteriovenous Graft vs Arteriovenous Fistula for First-time Permanent Hemodialysis Access.
Hicks CW; Wang P; Kernodle A; Lum YW; Black JH; Makary MA
JAMA Surg; 2019 Sep; 154(9):844-851. PubMed ID: 31188411
[TBL] [Abstract][Full Text] [Related]
10. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
[TBL] [Abstract][Full Text] [Related]
11. Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation.
Yuo TH; Chaer RA; Dillavou ED; Leers SA; Makaroun MS
J Vasc Surg; 2015 Dec; 62(6):1590-7.e2. PubMed ID: 26372193
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
13. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.
Lee HF; See LC; Chan YH; Yeh YH; Wu LS; Liu JR; Tu HT; Wang CL; Kuo CT; Chang SH
Intern Med J; 2018 Sep; 48(9):1123-1132. PubMed ID: 29808610
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
15. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
16. [One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Medvegy M; Wittmann I
Orv Hetil; 2023 Aug; 164(34):1337-1341. PubMed ID: 37634155
[TBL] [Abstract][Full Text] [Related]
17. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
[TBL] [Abstract][Full Text] [Related]
18. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
19. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
Slayden GC; Spergel L; Jennings WC
Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
